Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.

dc.contributor.authorThakur, Sidharath Dev
dc.contributor.authorAraya, Pamela
dc.contributor.authorBorthagaray, Graciela
dc.contributor.authorGalarza, Patricia
dc.contributor.authorHernandez, Alina Llop
dc.contributor.authorPayares, Daisy
dc.contributor.authorSanabria Cruz, Olga Marina
dc.contributor.authorCarvallo, Maria Elena Trigoso
dc.contributor.authorCorredor, Aura Helena
dc.contributor.authorDillon, Jo-Anne R
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:05:45Z
dc.date.available2026-03-24T15:05:45Z
dc.date.issued2017
dc.descriptionVol. 44, No. 3, pp. 157-160
dc.description.abstractSeven countries in Latin America and the Caribbean report on (2010 and 2011) the susceptibility of 2235 isolates of Neisseria gonorrhoeae to 6 antibiotics. Thirteen isolates had ceftriaxone minimum inhibitory concentrations (MICs) of 0.125 to ≥ 0.25 mg/L. The percentage of resistant isolates to the following antibiotics was: azithromycin, 1.0% to 1.7%; ciprofloxacin, 42.1% to 36.2%; penicillin, 31% to 35%; tetracycline, 21.8% to 22.6%.eng
dc.description.sponsorshipFrom the *Department of Microbiology, College of Medicine, †Vaccine and infectious Disease Organization-International Vaccine Center, University of Saskatchewan, Saskatchewan, Canada; ‡Instituto de Salud Publica de Chile, Santiago, Chile; §Faculdad de Quimica, Universidad de la Republica, Montivideo, Uruguay; ¶Instituto Nacional de Enfermedades Infecciosas-ANLIS "Dr Carlos Malbrán", Buenos Aires, Argentina; ∥Instituto de Medicina Tropical "Pedro Kouri", Ministerio Salud Publica, Habana, Cuba; **
dc.identifier.doi10.1097/OLQ.0000000000000587
dc.identifier.issn1537-4521
dc.identifier.otherPMID:28178114
dc.identifier.urihttps://doi.org/10.1097/OLQ.0000000000000587
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/101171
dc.language.isoeng
dc.relation.ispartofSexually transmitted diseases
dc.sourcePubMed
dc.titleResistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
dc.typeArtículo Científico Publicado

Files